Results 261 to 270 of about 3,125,604 (306)
Some of the next articles are maybe not open access.
A Gene Signature in Breast Cancer
New England Journal of Medicine, 2007Sunnybrook Health Sciences Centre Toronto, ON M4N 3M5, Canada Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808. [Erratum, Lancet Oncol 2005;6:826.] Kerlikowske K. The mammogram that cried Wolfe. N Engl J Med 2007;356:297-300.
Francois, Bertucci +2 more
openaire +3 more sources
Gene Signatures in Gastric Cancer
2011Although the incidence and mortality of Gastric Cancer (GC) have fallen over the past 70 years, GC continues to be the second leading cause of cancer death and the fourth most common malignant neoplasia across the world. GC still represents a major clinical challenge because it has a poor prognosis and limited treatment options due to its relative ...
L. Ottini, M. Falchetti, NESI, GABRIELLA
openaire +3 more sources
Horizontal Gene Transfer in Cyanobacterial Signature Genes
2009Comparison of 15 phylogenetically diverse cyanobacterial genomes identified an updated list of 183 signature genes that are widely found in cyanobacteria but absent in non-cyanobacterial species. These signature genes comprise the unique portion of the core cyanobacterial phenotype, and their absence from other lineages implies that if they arose by ...
Shailaja, Yerrapragada +2 more
openaire +2 more sources
Gene Signatures in the Management of Hepatocellular Carcinoma
Seminars in Oncology, 2012Clinical management of hepatocellular carcinoma (HCC) is a complex process. Currently existing prognostic staging systems have substantially improved the clinical outcome of patients by guiding treatment decision and allocation of medical resources.
Yujin, Hoshida +4 more
openaire +2 more sources
Scleroderma gene expression and pathway signatures
Current Rheumatology Reports, 2008Gene expression studies in scleroderma have shown large and consistent changes in the gene expression of end-target tissues. These changes reflect the lymphocyte infiltration and pathway deregulation potentially linked to disease pathogenesis. Gene expression in scleroderma also reflects the clinical heterogeneity in the disease and can be used to ...
Jennifer L, Sargent +3 more
openaire +2 more sources
Gene-Expression Signatures in Oncology Diagnostics
Pharmacogenomics, 2006The advent of DNA microarray technologies has enabled the development of gene expression signatures that can be used for prognostic and predictive purposes. This new information can change the paradigm of how medicine is practiced, coupling physical examination, pathology and clinical tests with new molecular information.
Abhijit, Mazumder, Yixin, Wang
openaire +2 more sources
Common gene signature of cancer and longevity
Mechanisms of Ageing and Development, 2009An association between aging/longevity and cancer has long been suggested, yet the evolutionary and molecular links between these complicated traits remain elusive. Here, we analyze the relationship between longevity- and cancer-associated genes/proteins (LAGs/LAPs and CAGs/CAPs, respectively).
Arie, Budovsky +5 more
openaire +2 more sources
Der Pathologe, 2011
This review reports the main gene signature specific for the diagnosis, prognosis or prediction of drug response in sarcomas. Almost half of sarcomas show a simple genetic lesion which is specific for the diagnosis: recurrent translocations in 10 to 15% of sarcomas, specific activating and inactivating mutations in GIST and rhabdoid tumor respectively,
F, Chibon, J-M, Coindre
openaire +1 more source
This review reports the main gene signature specific for the diagnosis, prognosis or prediction of drug response in sarcomas. Almost half of sarcomas show a simple genetic lesion which is specific for the diagnosis: recurrent translocations in 10 to 15% of sarcomas, specific activating and inactivating mutations in GIST and rhabdoid tumor respectively,
F, Chibon, J-M, Coindre
openaire +1 more source
Gene expression signatures in lymphoid tumours
Immunology & Cell Biology, 2004Lymphoid tumours comprise the acute and chronic leukaemias, the broad spectrum of lymphomas, including Hodgkin's disease, and multiple myeloma. The subdivision of the acute leukaemias according to the proliferating type of white blood cells has had a major impact on the care of these patients.
openaire +2 more sources
UCell: Robust and scalable single-cell gene signature scoring
Computational and Structural Biotechnology Journal, 2021Santiago J. Carmona, Massimo Andreatta
exaly